MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1)

Wang, Y; Guo, DM; Li, BB; Wang, YY; Wang, B; Wang, Z; Wang, M; Teng, QL

Teng, QL (通讯作者)，Taian City Cent Hosp, Dept Hematol, 29 Longtan Rd, Tai An, Shandong, Peoples R China.

LEUKEMIA RESEARCH, 2022; 112 ():

Abstract

Diffuse large B cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma worldwide, is aggressive and highly heterogeneous. MiR-665 was fou......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索